Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Most patients experience significant weight loss by the three-month mark
Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved
Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A [PMID: 42487660] Laboratory literature summary: Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report
Al-Nema et al., 2022b)
Hypothyroidism and Fatigue In research published in 2016, when hypothyroid patients received levothyroxine, the extra thyroid hormone promoted carnitine synthesis
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
